PL370792A1 - Doustny preparat Fludara o najwyższym stopniu czystości o szybkim uwalnianiu substancji czynnej - Google Patents

Doustny preparat Fludara o najwyższym stopniu czystości o szybkim uwalnianiu substancji czynnej

Info

Publication number: PL370792A1
Authority: PL; Poland
Prior art keywords: fludara; ultrapure; oral; formulation; active substance
Prior art date: 2001-12-20

Application number

PL02370792A

Other languages

English (en)

Other versions

PL203451B1 (pl

Inventor

Wolfgang Heil

Ulf Tilstam

Ralph Lipp

Johannes-Wilhelm Tack

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-20

Filing date

2002-11-25

Publication date

2005-05-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7711168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL370792(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-11-25 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2005-05-30 Publication of PL370792A1 publication Critical patent/PL370792A1/pl

2009-10-30 Publication of PL203451B1 publication Critical patent/PL203451B1/pl

Links

239000013543 active substance Substances 0.000 title 1
GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 title 1
229960005304 fludarabine phosphate Drugs 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)

PL370792A 2001-12-20 2002-11-25 Doustny preparat Fludara o najwy zszym stopniu czysto sci o szybkim uwalnianiu substancji czynnej PL203451B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10164510.4		2001-12-20
DE10164510A DE10164510A1 (de)	2001-12-20	2001-12-20	Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes

Publications (2)

Publication Number	Publication Date
PL370792A1 true PL370792A1 (pl)	2005-05-30
PL203451B1 PL203451B1 (pl)	2009-10-30

Family

ID=

Also Published As

Publication number	Publication date
ATE303797T1 (de)	2005-09-15
IL162555A0 (en)	2005-11-20
AU2002349043B2 (en)	2007-08-16
ECSP045185A (es)	2004-08-27
US20030176391A1 (en)	2003-09-18
UY27596A1 (es)	2003-07-31
DE50204203D1 (de)	2005-10-13
IL162555A (en)	2008-03-20
NZ533701A (en)	2006-03-31
KR20040073501A (ko)	2004-08-19
MXPA04006005A (es)	2004-09-27
ZA200405735B (en)	2006-01-25
BR0215265A (pt)	2004-12-07
NO20043063L (no)	2004-07-19
RS50398B (sr)	2009-12-31
EP1455760A1 (de)	2004-09-15
JO2363B1 (en)	2006-12-12
TW200305428A (en)	2003-11-01
JP2005519043A (ja)	2005-06-30
AU2002349043A1 (en)	2003-07-09
AR037965A1 (es)	2004-12-22
HRP20040648A2 (en)	2004-10-31
CA2471396A1 (en)	2003-07-03
ES2248624T3 (es)	2006-03-16
WO2003053418A1 (de)	2003-07-03
RS53304A (sr)	2006-10-27
RU2318496C2 (ru)	2008-03-10
HRP20040648B1 (en)	2012-11-30
KR100884685B1 (ko)	2009-02-18
TWI255187B (en)	2006-05-21
SA03240091B1 (ar)	2006-11-25
EP1455760B1 (de)	2005-09-07
UA78741C2 (en)	2007-04-25
DK1455760T3 (da)	2006-01-02
CN1306929C (zh)	2007-03-28
US7148207B2 (en)	2006-12-12
PE20030639A1 (es)	2003-08-28
RU2004122479A (ru)	2005-05-20
HK1077741A1 (en)	2006-02-24
JP2006137771A (ja)	2006-06-01
DE10164510A1 (de)	2003-07-10
CN1617713A (zh)	2005-05-18

Publication	Publication Date	Title
GB0104786D0 (en)	2001-04-18	Active Matrix Device
EP1434601A4 (en)	2009-08-19	INSULIN PREPARATIONS ENCAPSULATED IN LIPOSOMES
EG23943A (en)	2008-01-22	Flash-melt oral dosage formulation
SI1272167T1 (sl)	2008-12-31	Dozirna formulacija, ki vsebuje ropinirol, s hidrofilnim/lipofilnim polimernimm matriksom
IL159048A0 (en)	2004-05-12	Sustained release formulation
GB0008837D0 (en)	2000-05-31	Formulation
GB0014074D0 (en)	2000-08-02	Active matrix array devices
AU2002352865A1 (en)	2003-06-17	Ball grid array package
AUPQ676800A0 (en)	2000-05-11	Dental device
AU2001250032A1 (en)	2001-12-11	Oral care device
GB0000891D0 (en)	2000-03-08	Formulation
GB0031039D0 (en)	2001-01-31	Active matrix devices
HUP0500638A3 (en)	2008-04-28	Flashmelt oral dosage formulation
PL363536A1 (pl)	2004-11-29	Preparat agrochemiczny
PL367280A1 (pl)	2005-02-21	Preparaty agrochemiczne
HRP20040648B1 (en)	2012-11-30	Ultrapure oral fludara formulation with a fast releasing active substance
EP1545476A4 (en)	2008-01-09	CHRONOTHERAPEUTIC DILTIAZEM PREPARATIONS AND THEIR ADMINISTRATION
HUP0001430A3 (en)	2004-03-29	Manufacturing device
AU2002251448A1 (en)	2002-10-15	Oral absorbed drugs
PL366067A1 (pl)	2005-01-24	Preparat w postaci tabletki z oksazolidynonem
GB0125492D0 (en)	2001-12-12	Formulation
GB2362802B (en)	2003-12-03	Head-band locking device
GB0101992D0 (en)	2001-03-14	Pesticidal formulation
MXPA03007272A (es)	2003-12-04	Formulacion de medicamento que contiene agonista muscarinico.
IL147063A0 (en)	2002-08-14	Pesticidal formulation